115 related articles for article (PubMed ID: 9373203)
1. Simultaneous expression of P-glycoprotein and BCL-2 in acute myeloid leukemia blast cells.
Campos L; Oriol P; Sabido O; Guyotat D
Leuk Lymphoma; 1997 Sep; 27(1-2):119-25. PubMed ID: 9373203
[TBL] [Abstract][Full Text] [Related]
2. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
5. Bcl-x(L) is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression.
Pallis M; Zhu YM; Russell NH
Leukemia; 1997 Jul; 11(7):945-9. PubMed ID: 9204973
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
Bradbury DA; Zhu YM; Russell NH
Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
[TBL] [Abstract][Full Text] [Related]
7. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.
Lauria F; Raspadori D; Rondelli D; Ventura MA; Fiacchini M; Visani G; Forconi F; Tura S
Leukemia; 1997 Dec; 11(12):2075-8. PubMed ID: 9447823
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
9. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
10. In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy.
Kasimir-Bauer S; Ottinger H; Meusers P; Beelen DW; Brittinger G; Seeber S; Scheulen ME
Exp Hematol; 1998 Nov; 26(12):1111-7. PubMed ID: 9808049
[TBL] [Abstract][Full Text] [Related]
11. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).
Del Poeta G; Venditti A; Del Principe MI; Maurillo L; Buccisano F; Tamburini A; Cox MC; Franchi A; Bruno A; Mazzone C; Panetta P; Suppo G; Masi M; Amadori S
Blood; 2003 Mar; 101(6):2125-31. PubMed ID: 12424199
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between cyclin B1 and multidrug resistance in adult patients with acute leukemia].
Ma WD; Xu SR; Guo XN; Gao XL; Ma J; Qiao SK
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):169-72. PubMed ID: 12816698
[TBL] [Abstract][Full Text] [Related]
13. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.
Tóthová E; Fricova M; Stecová N; Kafková A; Elbertová A
Neoplasma; 2002; 49(3):141-4. PubMed ID: 12097997
[TBL] [Abstract][Full Text] [Related]
14. High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.
Karakas T; Maurer U; Weidmann E; Miething CC; Hoelzer D; Bergmann L
Ann Oncol; 1998 Feb; 9(2):159-65. PubMed ID: 9553660
[TBL] [Abstract][Full Text] [Related]
15. Membrane transport and apoptosis-related proteins in radiation-associated acute myeloid leukemia following the Chornobyl accident.
Klymenko SV; Ilyenko IN; Golarnik NA; Maznichenko OL; Breier A; Bazyka DA
Gen Physiol Biophys; 2009 Mar; 28(1):63-9. PubMed ID: 19390138
[TBL] [Abstract][Full Text] [Related]
16. Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells.
Flandrin P; Guyotat D; Duval A; Cornillon J; Tavernier E; Nadal N; Campos L
Cell Stress Chaperones; 2008 Sep; 13(3):357-64. PubMed ID: 18386162
[TBL] [Abstract][Full Text] [Related]
17. P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia.
Damiani D; Michieli M; Michelutti A; Fanin R; Russo D; Baccarani M
Leuk Lymphoma; 1995 Apr; 17(3-4):289-94. PubMed ID: 8580798
[TBL] [Abstract][Full Text] [Related]
18. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
[TBL] [Abstract][Full Text] [Related]
20. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.
Bradbury DA; Russell NH
Br J Haematol; 1995 Oct; 91(2):374-9. PubMed ID: 8547078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
